FDA commish Hahn spotlights Oct 22 vaccine advisory meeting as the next big flashpoint in the Covid-19 campaign
Mark October 22 on your calendars if you want to watch the next big controversy over the rapid-fire development of Covid-19 vaccines play out at the FDA.
Embattled FDA commissioner Stephen Hahn was back on Twitter Wednesday, offering assurances and spotlighting the virtual session being planned by the vaccine advisory board, and he’s clearly ready to lay out all the Covid-19 data available — 12 days ahead of the election.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.